Supporting this argument is our observation that simultaneous knockdown of all four members of the TBX2 subfamily, but not of individual TBXs, attenuated the anti-growth effects of the DNA methyltransferase and cancer drug 5-azacytidine. The gene discussed is TBX2; the disease is cancer.